Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives.

embryo hematopoiesis hematopoietic differentiation hemogenic endothelium induced pluripotent stem cells reprogramming

Journal

Stem cells translational medicine
ISSN: 2157-6580
Titre abrégé: Stem Cells Transl Med
Pays: England
ID NLM: 101578022

Informations de publication

Date de publication:
12 2020
Historique:
received: 09 06 2020
revised: 01 07 2020
accepted: 08 07 2020
pubmed: 30 7 2020
medline: 1 9 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

The generation of hematopoietic stem cells (HSCs) from induced pluripotent stem cells (iPSCs) is an active and promising area of research; however, generating engraftable HSCs remains a major obstacle. Ex vivo HSC derivation from renewable sources such as iPSCs offers an experimental tool for studying developmental hematopoiesis, disease modeling, and drug discovery, and yields tremendous therapeutic potential for malignant and nonmalignant hematological disorders. Although initial attempts mostly recapitulated yolk sac primitive/definitive hematopoiesis with inability to engraft, recent advances suggest the feasibility of engraftable HSC derivation from iPSCs utilizing ectopic transcription factor expression. Strategic development for de novo HSC generation includes further investigations of HSC ontogeny, and elucidation of critical signaling pathways, epigenetic modulations, HSC and iPSC microenvironment, and cell-cell interactions that contribute to stem cell biology and function.

Identifiants

pubmed: 32725882
doi: 10.1002/sctm.20-0247
pmc: PMC7695636
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1549-1557

Informations de copyright

© 2020 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals LLC on behalf of AlphaMed Press.

Références

Nature. 2020 Jun;582(7813):571-576
pubmed: 32499656
Stem Cells Transl Med. 2020 May;9(5):590-602
pubmed: 32034898
Blood. 2004 Jul 1;104(1):19-25
pubmed: 15031208
Nature. 2017 May 25;545(7655):432-438
pubmed: 28514439
Biol Blood Marrow Transplant. 2008 Aug;14(8):938-41
pubmed: 18640578
Nature. 2010 Mar 4;464(7285):112-5
pubmed: 20154732
Adv Exp Med Biol. 2018;1107:1-13
pubmed: 29876866
Mol Ther. 2013 Jul;21(7):1424-31
pubmed: 23670574
Blood. 2018 Sep 27;132(13):1372-1378
pubmed: 30089629
Nat Rev Genet. 2011 Apr;12(4):231-42
pubmed: 21339765
Blood. 2013 Feb 21;121(8):1255-64
pubmed: 23212524
Nat Cell Biol. 2019 Nov;21(11):1334-1345
pubmed: 31685991
Development. 1999 Sep;126(17):3735-45
pubmed: 10433904
Nature. 2012 Jan 18;481(7381):295-305
pubmed: 22258608
Cell Res. 2020 Jan;30(1):21-33
pubmed: 31729468
Haematologica. 2010 Oct;95(10):1651-9
pubmed: 20494935
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Expert Rev Hematol. 2018 Jul;11(7):547-565
pubmed: 29883237
J Exp Med. 2019 Jul 1;216(7):1599-1614
pubmed: 31076455
FEBS Lett. 2016 Nov;590(22):3965-3974
pubmed: 27790707
Stem Cells Transl Med. 2020 Dec;9(12):1549-1557
pubmed: 32725882
Blood. 2002 Feb 15;99(4):1183-9
pubmed: 11830464
Cytotherapy. 2018 Jul;20(7):899-910
pubmed: 29859773
N Engl J Med. 2018 Apr 19;378(16):1479-1493
pubmed: 29669226
Dev Cell. 2005 Mar;8(3):365-75
pubmed: 15737932
Blood. 2005 Aug 1;106(3):860-70
pubmed: 15831705
Nature. 1981 Jul 9;292(5819):154-6
pubmed: 7242681
PLoS Biol. 2004 Mar;2(3):E75
pubmed: 15024423
Blood. 2013 Mar 7;121(10):e70-80
pubmed: 23303822
EMBO J. 2000 Jun 1;19(11):2465-74
pubmed: 10835345
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20838-43
pubmed: 18087045
Blood. 2013 Feb 21;121(8):1469-76
pubmed: 23258921
Cell Rep. 2012 Dec 27;2(6):1722-35
pubmed: 23219550
J Exp Med. 2005 May 16;201(10):1603-14
pubmed: 15883170
Br J Haematol. 2020 May;189(3):408-423
pubmed: 32034776
Cell. 2014 Apr 24;157(3):549-64
pubmed: 24766805
Cell Stem Cell. 2013 Oct 3;13(4):459-70
pubmed: 24094326
Haematologica. 2012 Dec;97(12):1795-803
pubmed: 22733021
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10716-21
pubmed: 11535826
Blood Adv. 2018 Aug 14;2(15):1998-2011
pubmed: 30108108
Blood. 2011 Apr 28;117(17):4600-8
pubmed: 21378272
Mol Ther. 2011 Apr;19(4):635-8
pubmed: 21455209
Stem Cells. 2015 Apr;33(4):1130-41
pubmed: 25546363
Science. 2016 Feb 12;351(6274):aad5510
pubmed: 26797145
J Cell Physiol. 2020 Mar;235(3):2080-2090
pubmed: 31389001
Blood. 2010 Oct 28;116(17):3321-30
pubmed: 20628147
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2180-2185
pubmed: 29386396
Cell Stem Cell. 2013 Aug 1;13(2):149-59
pubmed: 23910082
Blood. 2013 Oct 3;122(14):2338-45
pubmed: 23863896
Dev Cell. 2020 Feb 24;52(4):446-460.e5
pubmed: 32032546
Pediatr Res. 1996 Jan;39(1):166-70
pubmed: 8825404
Cell Rep. 2015 Jun 30;11(12):1892-904
pubmed: 26095363
Development. 1999 Nov;126(22):5073-84
pubmed: 10529424
Nat Commun. 2020 Jun 1;11(1):2713
pubmed: 32483127
Sci Transl Med. 2017 Feb 8;9(376):
pubmed: 28179501
Front Cardiovasc Med. 2018 Jan 25;5:4
pubmed: 29423397
Cell. 2002 Apr 5;109(1):29-37
pubmed: 11955444
N Engl J Med. 2009 Dec 10;361(24):2309-17
pubmed: 20007560
Nat Commun. 2020 Jan 29;11(1):586
pubmed: 31996681
Cell Res. 2020 May;30(5):376-392
pubmed: 32203131
Nat Biotechnol. 2019 Mar;37(3):252-258
pubmed: 30778232
FEBS Lett. 2019 Dec;593(23):3288-3303
pubmed: 31520530
Cell Rep. 2020 May 12;31(6):107627
pubmed: 32402290
Ann N Y Acad Sci. 2020 Apr;1466(1):39-50
pubmed: 31199002
Proc Natl Acad Sci U S A. 2019 May 21;116(21):10441-10446
pubmed: 31040209
Stem Cell Reports. 2017 Oct 10;9(4):1024-1033
pubmed: 28943250
Cell Stem Cell. 2008 Jul 3;3(1):85-98
pubmed: 18593561
Blood. 2003 Aug 1;102(3):906-15
pubmed: 12702499
Nat Cell Biol. 2015 May;17(5):580-91
pubmed: 25915127
Blood. 2020 Aug 13;136(7):845-856
pubmed: 32392346
J Leukoc Biol. 1989 Feb;45(2):87-96
pubmed: 2536795
Stem Cells. 2017 Mar;35(3):586-596
pubmed: 27739611
Semin Hematol. 2018 Apr;55(2):87-93
pubmed: 29958564
Nature. 2015 Feb 26;518(7540):547-51
pubmed: 25470051
Br J Haematol. 2019 Jul;186(2):286-299
pubmed: 30972754
Blood. 2007 Feb 15;109(4):1433-41
pubmed: 17062726
Blood. 2012 May 24;119(21):4828-37
pubmed: 22337720
Leukemia. 2013 Apr;27(5):1000-8
pubmed: 23212154
Cell Stem Cell. 2019 Apr 4;24(4):566-578.e7
pubmed: 30853558
Stem Cell Res. 2019 Dec;41:101600
pubmed: 31710911
Stem Cells Dev. 2019 Dec 1;28(23):1540-1551
pubmed: 31595840
Development. 2016 Dec 15;143(24):4571-4581
pubmed: 27965438
J Clin Invest. 2015 Mar 2;125(3):1243-54
pubmed: 25664855
Circ Res. 2003 Feb 7;92(2):133-5
pubmed: 12574139
Cell Stem Cell. 2008 Jul 3;3(1):99-108
pubmed: 18593562
Nat Biotechnol. 2017 Aug;35(8):765-772
pubmed: 28504668
Science. 2007 Dec 21;318(5858):1917-20
pubmed: 18029452
Stem Cells Dev. 2014 Jun 1;23(11):1168-77
pubmed: 24417306

Auteurs

Selami Demirci (S)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland, USA.

Alexis Leonard (A)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland, USA.

John F Tisdale (JF)

Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH